Adenovirus type 5 exerts multiple effects on the expression and activity of cytosolic phospholipase A2, cyclooxygenase-2, and prostaglandin synthesis.
In this study, we examine how infection of murine and human fibroblasts by adenovirus (Ad) serotype 5 (Ad5) affects the expression and activity of cytosolic phospholipase A2 (cPLA2), cyclooxygenase-2 (COX-2), and production of PGs. Our experiments showed that infection with Ad5 is accompanied by the rapid activation of cPLA2 and the cPLA2-dependent release of [3H]arachidonic acid ([3H]AA). Increased expression of COX-2 was also observed after Ad infection, as was production of PGE2 and PGI2. Later, however, as the infection progressed, release of [3H]AA and production of PGs stopped. Late-stage Ad5-infected cells also did not release [3H]AA or PGs following treatment with a panel of biologically diverse agents. Experiments with UV-inactivated virus confirmed that Ad infection is accompanied by the activation of a host-dependent response that is later inhibited by the virus. Investigations of the mechanism of suppression of the PG pathway by Ad5 did not reveal major effects on the expression or activity of cPLA2 or COX-2. We did note a change in the intracellular position of cPLA2 and found that cPLA2 did not translocate normally in infected cells, raising the possibility that Ad5 interferes with the PG pathway by interfering with the intracellular movement of cPLA2. Taken together, these data reveal dynamic interactions between Ad5 and the lipid mediator pathways of the host and highlight a novel mechanism by which Ad5 evades the host immune response. In addition, our results offer insight into the inflammatory response induced by many Ad vectors lacking early region gene products.
Culver
Carolyn A
CA
Department of Microbiology, North Carolina State University, Raleigh, NC 27695, USA.
Laster
Scott M
SM
D000260:Adenoviruses, Human / Q000235:genetics / Q000276:immunology*; D000818:Animals; D016718:Arachidonic Acid / Q000037:antagonists & inhibitors / Q000378:metabolism; D002460:Cell Line; D045744:Cell Line, Tumor; D051546:Cyclooxygenase 2 / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism*; D015232:Dinoprostone / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D004789:Enzyme Activation / Q000276:immunology; D011464:Epoprostenol / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D005347:Fibroblasts / Q000201:enzymology / Q000378:metabolism / Q000821:virology; D054513:Group IV Phospholipases A2; D006801:Humans; D007424:Intracellular Fluid / Q000201:enzymology / Q000821:virology; D051379:Mice; D010741:Phospholipases A / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism*; D054467:Phospholipases A2; D011453:Prostaglandins / Q000096:biosynthesis*; D021381:Protein Transport / Q000276:immunology; D014316:Tritium